skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Epigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus Vaccine

Journal Article · · Scientific Reports
DOI:https://doi.org/10.1038/srep33987· OSTI ID:1396131
ORCiD logo [1];  [2]; ORCiD logo [1];  [3];  [3];  [1]
  1. Los Alamos National Lab. (LANL) and New Mexico Consortium, Los Alamos, NM (United States)
  2. Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
  3. Oregon Health and Science Univ., Portland, OR (United States)

Epigraph is an efficient graph-based algorithm for designing vaccine antigens to optimize potential T-cell epitope (PTE) coverage. Functionally, epigraph vaccine antigens are similar to Mosaic vaccines, which have demonstrated effectiveness in preliminary HIV non-human primate studies. In contrast to the Mosaic algorithm, Epigraph is substantially faster, and in restricted cases, provides a mathematically optimal solution. Furthermore, epigraph has new features that enable enhanced vaccine design flexibility. These features include the ability to exclude rare epitopes from a design, to optimize population coverage based on inexact epitope matches, and to apply the code to both aligned and unaligned input sequences. Epigraph was developed to provide practical design solutions for two outstanding vaccine problems. The first of these is a personalized approach to a therapeutic T-cell HIV vaccine that would provide antigens with an excellent match to an individual’s infecting strain, intended to contain or clear a chronic infection. The second is a pan-filovirus vaccine, with the potential to protect against all known viruses in the Filoviradae family, including ebolaviruses. A web-based interface to run the Epigraph tool suite is available (http://www.hiv.lanl.gov/content/sequence/EPIGRAPH/epigraph.html).

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE; National Institutes of Health (NIH)
Grant/Contract Number:
AC52-06NA25396; NIAID 2 R44; AI100343-02; CHAVI-ID; UM1-AI100645
OSTI ID:
1396131
Report Number(s):
LA-UR-17-24455
Journal Information:
Scientific Reports, Vol. 6, Issue 1; ISSN 2045-2322
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 25 works
Citation information provided by
Web of Science

References (40)

An Eulerian path approach to DNA fragment assembly journal August 2001
Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants journal December 2006
Immune clearance of highly pathogenic SIV infection journal September 2013
Designing and Testing Broadly-Protective Filoviral Vaccines Optimized for Cytotoxic T-Lymphocyte Epitope Coverage journal October 2012
Depth-First Search and Linear Graph Algorithms journal June 1972
Hepatitis C Genotype 1 Mosaic Vaccines Are Immunogenic in Mice and Induce Stronger T-Cell Responses than Natural Strains journal December 2012
How to apply de Bruijn graphs to genome assembly journal November 2011
Cytomegalovirus Vectors Violate CD8+ T Cell Epitope Recognition Paradigms journal May 2013
Identification of common molecular subsequences journal March 1981
Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine journal October 2007
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys journal February 2010
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates journal August 2011
A systematic approach to dynamic programming in bioinformatics journal August 2000
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys journal February 2010
Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys journal October 2013
Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine journal August 2015
Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing journal August 2010
Mosaic HIV-1 Gag Antigens Can Be Processed and Presented to Human HIV-Specific CD8 + T Cells journal May 2011
Altered Response Hierarchy and Increased T-Cell Breadth upon HIV-1 Conserved Element DNA Vaccination in Macaques journal January 2014
Discovery of an Ebolavirus-Like Filovirus in Europe journal October 2011
Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape journal May 2012
Evaluation of Perceived Threat Differences Posed by Filovirus Variants journal December 2011
Definition of the viral targets of protective HIV-1-specific T cell responses journal January 2011
Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection journal April 2016
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial journal August 2015
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus journal April 2013
Broad Protection against Avian Influenza Virus by Using a Modified Vaccinia Ankara Virus Expressing a Mosaic Hemagglutinin Gene journal September 2014
Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition journal February 2016
Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens journal July 2012
Diversity Considerations in HIV-1 Vaccine Selection journal June 2002
Integrated sequence and immunology filovirus database at Los Alamos journal January 2016
Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA journal November 2013
First Steps toward a Globally Effective HIV/AIDS Vaccine journal October 2013
T-Cell Vaccine Strategies for Human Immunodeficiency Virus, the Virus with a Thousand Faces journal May 2009
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost journal April 2015
Full-Length HIV-1 Immunogens Induce Greater Magnitude and Comparable Breadth of T Lymphocyte Responses to Conserved HIV-1 Regions Compared with Conserved-Region-Only HIV-1 Immunogens in Rhesus Monkeys journal August 2012
Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses journal October 2015
Short Conserved Sequences of HIV-1 Are Highly Immunogenic and Shift Immunodominance journal November 2014
Molecular Evolution of Viruses of the Family Filoviridae Based on 97 Whole-Genome Sequences journal December 2012
Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection text January 2016

Cited By (7)

Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding journal August 2018
Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials journal October 2019
HIV Diversity and Genetic Compartmentalization in Blood and Testes during Suppressive Antiretroviral Therapy journal June 2019
Complete protection of the BALB/c and C57BL/6J mice against Ebola and Marburg virus lethal challenges by pan-filovirus T-cell epigraph vaccine journal February 2019
Author Correction: Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding journal November 2018
Polyvalent vaccine approaches to combat HIV-1 diversity journal January 2017
Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines journal April 2017

Similar Records

Candidate mosaic proteins for a pan-filoviral cytotoxic T-Cell lymphocyte vaccine
Journal Article · Tue Jan 01 00:00:00 EST 2008 · Journal of Virology · OSTI ID:1396131

Expanded breadth of the T-cell response to mosaic HIV-1 envelope DNA vaccination
Journal Article · Thu Jan 01 00:00:00 EST 2009 · Journal of Virology · OSTI ID:1396131

Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design
Journal Article · Thu Aug 25 00:00:00 EDT 2016 · PLoS Pathogens · OSTI ID:1396131